Close Menu

NEW YORK – Quanterix reported after the close of the market on Thursday that its third quarter revenues rose 111 percent year over year, driven by one-time license and grant revenue.

For the three months ended Sept. 30, the Billerica, Massachusetts-based company posted Q3 revenues of $31.4 million, up from $14.9 million in Q3 2019, beating the consensus Wall Street estimate of $14.9 million. Excluding the one-time license and grant revenue, revenues were $18.3 million, up 22 percent over the prior year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The European Medicines Agency recommends that a warning about the possibility of blood clots be added to the product information.

According to Agence France Presse, astronauts who are to arrive soon at the International Space Station are to study the effect of microgravity on brain organoids and more.

A new study finds that farmed fish have led to a decline in genetic diversity among Atlantic salmon, the Guardian reports.

In Cell this week: analysis of SARS-CoV-2 B.1.1.7 introductions to the US, increased horizontal gene transfer higher in gut microbiomes linked to industrialization, and more.